ArticleAntimicrobial agents and chemotherapy2025

Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity.

Cole S Hudson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.